title: Efficient production of dual recombinant adeno-associated viral vectors for factor VIII delivery.
abstract: Recombinant adeno-associated viral (rAAV) vectors have gained attention for human gene therapy because of their high safety and clinical efficacy profile. For factor VIII gene delivery, splitting the coding region between two AAV vectors remains a viable strategy to avoid the packaging capacity limitation (∼5.0 kb). However, it is time-consuming and labor-intensive to produce two rAAV vectors in separate batches. Here we demonstrated successful production of dual rAAV vectors for hemophilia A gene therapy in a single preparation. When the AAV vector plasmids carrying the human factor VIII heavy chain (hHC) and the light chain (hLC) expression cassettes were cotransfected into 293 cells along with the AAV rep&cap and mini-adenovirus helper plasmids, both rAAV-hHC and rAAV-hLC were produced at the desired ratio and in high titer. Interestingly, the rAAV-hHC vectors always yielded higher titers than rAAV-hLC vectors as a result of more efficient replication of rAAV-hHC genomes. The resulting vectors were effective in transducing the tissue culture cells in vitro. When these vectors were administered to hemophilia A mice, factor VIII was detected in the mouse plasma by both the activated partial thromboplastin time assay and enzyme-linked immunosorbent assay. The functional activity as well as the antigen levels of secreted factor VIII were similar to those of vectors produced by the traditional method. The dual-vector production method has been successfully extended to both AAV2 and AAV8 serotypes. In conclusion, cotransfection of vector plasmids presents an efficient method for producing dual or multiple AAV vectors at significantly reduced cost and labor.
authors.affiliation: 1 Sol Sherry Thrombosis Research Center, Temple University , Philadelphia, PA 19140.
authors.forename: Qizhao
authors.initials: Q
authors.lastname: Wang
authors.forename: Biao
authors.initials: B
authors.lastname: Dong
authors.forename: Jenni
authors.initials: J
authors.lastname: Firrman
authors.forename: Sean
authors.initials: S
authors.lastname: Roberts
authors.forename: Andrea Rossi
authors.initials: AR
authors.lastname: Moore
authors.forename: Wenjing
authors.initials: W
authors.lastname: Cao
authors.forename: Yong
authors.initials: Y
authors.lastname: Diao
authors.forename: Philipp
authors.initials: P
authors.lastname: Kapranov
authors.forename: Ruian
authors.initials: R
authors.lastname: Xu
authors.forename: Weidong
authors.initials: W
authors.lastname: Xiao
mesh_terms: D000818:Animals; D000229:Dependovirus / Q000235:genetics*; D005169:Factor VIII / Q000235:genetics* / Q000378:metabolism; D015316:Genetic Therapy; D005822:Genetic Vectors / Q000378:metabolism* / Q000627:therapeutic use; D057809:HEK293 Cells; D006378:Helper Viruses / Q000235:genetics; D006467:Hemophilia A / Q000628:therapy*; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000235:genetics; D014162:Transfection / Q000379:methods*
chemical_list: D011994:Recombinant Proteins; D005169:Factor VIII
references.citation: Mol Ther. 2007 Oct;15(10):1856-62
references.pmid: 17653101
references.citation: Nucleic Acids Res. 2013 Jul;41(13):6609-17
references.pmid: 23677609
references.citation: J Virol. 2005 Mar;79(5):3146-62
references.pmid: 15709034
references.citation: Mol Ther. 2006 Sep;14(3):452-5
references.pmid: 16822719
references.citation: Hum Gene Ther. 2014 Mar;25(3):180-8
references.pmid: 24299335
references.citation: Hum Gene Ther. 2008 Jun;19(6):648-54
references.pmid: 18500941
references.citation: Mol Ther. 2010 Jan;18(1):80-6
references.pmid: 19904234
references.citation: Blood. 2013 Apr 25;121(17):3335-44
references.pmid: 23426947
references.citation: Astrobiology. 2010 May;10(4):437-47
references.pmid: 20528198
references.citation: Mol Ther. 2008 Jan;16(1):124-30
references.pmid: 17984978
references.citation: Blood. 2004 Feb 15;103(4):1253-60
references.pmid: 14551134
references.citation: Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2952-7
references.pmid: 15703296
references.citation: Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12725-30
references.pmid: 10535990
references.citation: J Gene Med. 2006 Mar;8(3):298-305
references.pmid: 16385549
references.citation: J Thromb Haemost. 2003 Feb;1(2):220-6
references.pmid: 12871492
references.citation: Blood. 2006 Mar 1;107(5):1810-7
references.pmid: 16249376
references.citation: Mol Ther. 2010 Sep;18(9):1731-5
references.pmid: 20606642
references.citation: Hum Gene Ther. 2014 Feb;25(2):98-108
references.pmid: 24191945
references.citation: Mol Ther. 2009 Mar;17(3):417-24
references.pmid: 19127250
references.citation: Mol Ther. 2001 Oct;4(4):383-91
references.pmid: 11592843
references.citation: Blood. 2013 May 23;121(21):4396-403
references.pmid: 23372167
references.citation: Nat Rev Drug Discov. 2012 May;11(5):419
references.pmid: 22679644
references.citation: Mol Ther. 2010 Jan;18(1):75-9
references.pmid: 19904238
references.citation: Hum Gene Ther. 2011 Jan;22(1):77-83
references.pmid: 20662564
references.citation: Thromb Res. 2006;118(5):627-35
references.pmid: 16371232
references.citation: Blood. 2003 Dec 1;102(12):3919-26
references.pmid: 12893764
references.citation: Mol Ther. 2013 Dec;21(12):2181-94
references.pmid: 23896725
references.citation: Mol Ther. 2012 Feb;20(2):443-55
references.pmid: 22068425
references.citation: Br J Haematol. 1999 Jan;104(1):27-36
references.pmid: 10027708
references.citation: Nat Biotechnol. 2005 Nov;23(11):1435-9
references.pmid: 16244658
references.citation: Hum Gene Ther. 2006 Oct;17(10):1036-42
references.pmid: 17007565
references.citation: Mol Ther. 2011 Mar;19(3):442-9
references.pmid: 21081906
references.citation: Mol Ther. 2002 Jun;5(6):716-22
references.pmid: 12027555
references.citation: Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13714-9
references.pmid: 11095710
references.citation: N Engl J Med. 2011 Dec 22;365(25):2357-65
references.pmid: 22149959
references.citation: EMBO Mol Med. 2014 Feb;6(2):194-211
references.pmid: 24150896
references.citation: Mol Ther. 2010 Jan;18(1):87-92
references.pmid: 19904236
references.citation: Gene Ther. 2013 Apr;20(4):361-9
references.pmid: 22717743
references.citation: Nat Biotechnol. 2002 Jul;20(7):697-701
references.pmid: 12089554
references.citation: Hum Gene Ther. 2007 Jan;18(1):81-7
references.pmid: 17181493
references.citation: Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6716-21
references.pmid: 10841568